The chemokine receptor antagonist TAK-779 decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system without affecting T cell function

摘要

Background and purpose:The C–C chemokine receptor CCR5, and the C–X–C chemokine receptor CXCR3 are involved in the regulation of T cell-mediated immune responses, and in the migration and activation of these cells. To determine whether blockade of these chemokine receptors modulated inflammatory responses in the central nervous sytem (CNS), we investigated the effect of a non-peptide chemokine receptor antagonist, TAK-779, in mice with experimental autoimmune encephalomyelitis (EAE).